These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 28068938)

  • 1. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.
    Han X; Wang L; Shi H; Zheng G; He J; Wu W; Shi J; Wei G; Zheng W; Sun J; Huang H; Cai Z
    BMC Cancer; 2017 Jan; 17(1):40. PubMed ID: 28068938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
    Cheng HL; Molassiotis A
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
    Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
    Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain.
    Zhi WI; Ingram E; Li SQ; Chen P; Piulson L; Bao T
    Integr Cancer Ther; 2018 Dec; 17(4):1079-1086. PubMed ID: 30027756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.
    Zirpoli GR; McCann SE; Sucheston-Campbell LE; Hershman DL; Ciupak G; Davis W; Unger JM; Moore HCF; Stewart JA; Isaacs C; Hobday TJ; Salim M; Hortobagyi GN; Gralow JR; Budd GT; Albain KS; Ambrosone CB
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29546345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.
    Ajewole VB; Cox JE; Swan JT; Chikermane SG; Lamoth B; Iso T; Okolo LO; Ford CL; Schneider AM; Hobaugh EC; Baker KR
    Support Care Cancer; 2020 Apr; 28(4):1901-1912. PubMed ID: 31359183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma.
    Bao T; Goloubeva O; Pelser C; Porter N; Primrose J; Hester L; Sadowska M; Lapidus R; Medeiros M; Lao L; Dorsey SG; Badros AZ
    Integr Cancer Ther; 2014 Sep; 13(5):396-404. PubMed ID: 24867959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electroacupuncture with different frequencies for paclitaxel-induced peripheral neuropathy: a randomized controlled trial].
    Lu C; Feng X; Shen Q; Li G; Wu T; Li X; Shao X; Wang P; Li R; Deng Y; Chen W
    Zhongguo Zhen Jiu; 2024 Oct; 44(10):1139-45. PubMed ID: 39401811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Clinical Trial.
    Bao T; Baser R; Chen C; Weitzman M; Zhang YL; Seluzicki C; Li QS; Piulson L; Zhi WI
    Oncologist; 2021 Nov; 26(11):e2070-e2078. PubMed ID: 34390283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes.
    Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB
    J Natl Compr Canc Netw; 2023 Feb; 21(2):125-132.e3. PubMed ID: 36791763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
    Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
    Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
    Parsons SK; Rodday AM; Pei Q; Keller FG; Wu Y; Henderson TO; Cella D; Kelly KM; Castellino SM
    J Patient Rep Outcomes; 2023 Nov; 7(1):113. PubMed ID: 37947987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice.
    Beijers AJ; Vreugdenhil G; Oerlemans S; Eurelings M; Minnema MC; Eeltink CM; van de Poll-Franse LV; Mols F
    Support Care Cancer; 2016 Jun; 24(6):2411-20. PubMed ID: 26634561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy.
    Wong R; Major P; Sagar S
    Integr Cancer Ther; 2016 Jun; 15(2):153-64. PubMed ID: 27130723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture May Help to Prevent Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Sham-Controlled, Single-Blind Study.
    Huang MC; Chang SC; Liao WL; Ke TW; Lee AL; Wang HM; Chang CP; Yen HR; Chang HH; Chen WT
    Oncologist; 2023 Jun; 28(6):e436-e447. PubMed ID: 36971468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy.
    Cheng HL; Lopez V; Lam SC; Leung AKT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; De Ng TR; Suen LKP; Chan CW; Yorke J; Molassiotis A
    Health Qual Life Outcomes; 2020 Jul; 18(1):246. PubMed ID: 32703223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy.
    Molassiotis A; Suen LKP; Cheng HL; Mok TSK; Lee SCY; Wang CH; Lee P; Leung H; Chan V; Lau TKH; Yeo W
    Integr Cancer Ther; 2019; 18():1534735419836501. PubMed ID: 30905173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and safety of acupuncture/electroacupuncture for chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Pei LX; Yi Y; Guo J; Chen L; Zhou JY; Wu XL; Sun JH; Chen H
    Acupunct Med; 2023 Apr; 41(2):73-85. PubMed ID: 35695033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study.
    Garcia MK; Cohen L; Guo Y; Zhou Y; You B; Chiang J; Orlowski RZ; Weber D; Shah J; Alexanian R; Thomas S; Romaguera J; Zhang L; Badillo M; Chen Y; Wei Q; Lee R; Delasalle K; Green V; Wang M
    J Hematol Oncol; 2014 May; 7():41. PubMed ID: 24886772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.
    Calhoun EA; Welshman EE; Chang CH; Lurain JR; Fishman DA; Hunt TL; Cella D
    Int J Gynecol Cancer; 2003; 13(6):741-8. PubMed ID: 14675309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.